Tissue Diagnostics Market By Product Type (Kits and Instruments), By Technology (Immuno Histochemistry, Digital Pathology, In-Situ Hybridization and Special Staining) By End User (Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Research Laboratories) - Global Industry Analysis & Forecast to 2023

Published On : August 2018 Pages : 185 Category: Biotechnology Report Code : HC081183

Industry Outlook and Trend Analysis

The Tissue Diagnostic Market was worth USD 2.98 billion in 2014 and is expected to reach approximately USD 5.40 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 6.82% during the forecast period. Tissue diagnostics includes expulsion of tissue at a micro level from the patient's body, which is then analyzed, processed, and tested under the magnifying lens to identify different diseases like cancer. Progressions in the equipment and methods of tissue diagnostics helps for quick and exact assurance and assessment of diseases identified with the tissues. Increasing incidences of cancer, quick increment in aging populace, and development in the spending plans for healthcare drive the market. Nonetheless, budget limitations and high level of union control the market development. Additionally, developing markets and expanded usage of customized medicine provide lucrative opportunities for the development of the market.

Drivers and Restraints

With the increasing incidences of cancer, the market for tissue diagnostics has received significant traction over the world. The infrastructural advancement in the healthcare and medical industry is another critical factor that has helped the worldwide tissue diagnostics market generously over the previous couple of years. Over the upcoming years, the rising pattern of the qualitative and quantitative analyses of tissue tests, revelation of target particular antibodies in the biopharmaceutical business, and the developing awareness about tissue diagnosis in rising economies are anticipated to be the most conspicuous factors behind the development of this market.

Market Segmentation

The Tissue Diagnostic Market is segmented on the basis of product, technology and end user. Based on product the market is segmented into Kits and Instruments out of which the instruments segment surfaced as the major contributor of this market in 2015, holding a share of over 77%. With the increasing application of tissue diagnostic instruments in hospitals, diagnostic centers, and labs for speedier and accurate analysis, the demand is foreseen to rise strikingly over the following couple of years. Based on technology the market is segmented into Digital Pathology, Immuno Histochemistry, In-Situ Hybridization and Special Staining. On the basis of end user the market is segmented into Diagnostic Centers, Ambulatory Surgical Centers, Hospitals, and Research Laboratories out of which Hospitals, with a major share, has acquired the position of the main contributor to this market and is foreseen to retain this over the upcoming years.

Regional Outlook and Trend Analysis

The Middle East and Africa, North America, Asia Pacific, Latin America, and Europe have risen as the prevalent geological portions of the overall tissue diagnostic market. With a share of around 40%, North America enlisted predominance over these in 2015, on account of a well-settled pharmaceutical and biotechnology industry and the expansion in research exercises. Experts anticipate that this local market will stay on the best finished the following couple of years on the grounds of the surging exploration capital, advent of enhanced and mechanically propelled tissue diagnostic devices, and the existence of the main market players in a huge number.

Competitive Insights

The leading players in the market are Becton Dickinson, Agilent Technologies, Genomic Health, GE Healthcare, 3DHISTECH, Thermo Fisher Scientific, Roche Diagnostics, Cell Signaling Technology, Abbott Laboratories and Danaher Corporation. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Tissue Diagnostic Market is segmented based on regions as follows-

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Tissue Diagnostics Market, By Product Type, Estimates and Forecast, 2014-2023($Billion)

o    Kits

o    Instruments

·         Tissue Diagnostics Market, By Technology, Estimates and Forecast, 2014-2023($Billion)

o    Immuno Histochemistry

o    Digital Pathology

o    In-Situ Hybridization

o    Special Staining

·         Tissue Diagnostics Market, By End User, Estimates and Forecast, 2014-2023($Billion)

o    Ambulatory Surgical Centers

o    Diagnostic Centers

o    Hospitals

o    Research Laboratories

·         Tissue Diagnostics Market, By Region, Estimates and Forecast, 2014-2023($Billion)

o    North America

§  North America Tissue Diagnostics Market, By Country

o    U.S. Tissue Diagnostics Market

o    Canada Tissue Diagnostics Market

o    Mexico Tissue Diagnostics Market

o    Europe

§  Europe Tissue Diagnostics Market, By Country

o    Germany Tissue Diagnostics Market

o    UK Tissue Diagnostics Market

o    France Tissue Diagnostics Market

o    Russia Tissue Diagnostics Market

o    Italy Tissue Diagnostics Market

o    Rest of Europe Tissue Diagnostics Market

o    Asia-Pacific

§  Asia-Pacific Tissue Diagnostics Market, By Country

o    China Tissue Diagnostics Market

o    Japan Tissue Diagnostics Market

o    South Korea Tissue Diagnostics Market

o    India Tissue Diagnostics Market

o    Southeast Asia Tissue Diagnostics Market

o    Rest of Asia-Pacific Tissue Diagnostics Market

o    South America

§  South America Tissue Diagnostics Market

o    Brazil Tissue Diagnostics Market

o    Argentina Tissue Diagnostics Market

o    Columbia Tissue Diagnostics Market

o    Rest of South America Tissue Diagnostics Market

o    Middle East and Africa

§  Middle East and Africa Tissue Diagnostics Market

o    Saudi Arabia Tissue Diagnostics Market

o    UAE Tissue Diagnostics Market

o    Egypt Tissue Diagnostics Market

o    Nigeria Tissue Diagnostics Market

o    South Africa Tissue Diagnostics Market

o    Rest of MEA Tissue Diagnostics Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

5.       Tissue Diagnostics Market, By Product Type

5.1.       Introduction

5.2.       Global Tissue Diagnostics Sales, Revenue and Market Share by Product Type (2014-2018)

5.2.1.  Global Tissue Diagnostics Sales and Sales Share by Product Type (2014-2018)

5.2.2.  Global Tissue Diagnostics Revenue and Revenue Share by Product Type (2014-2018)

5.3.       Kits  

5.3.1.  Global Kits Sales and Growth Rate (2014-2018)

5.4.       Instruments  

5.4.1.  Global Instruments Sales and Growth Rate (2014-2018)

6.       Tissue Diagnostics Market, By Technology

6.1.       Introduction

6.2.       Global Tissue Diagnostics Sales, Revenue and Market Share by Technology (2014-2018)

6.2.1.  Global Tissue Diagnostics Sales and Sales Share by Technology (2014-2018)

6.2.2.  Global Tissue Diagnostics Revenue and Revenue Share by Technology (2014-2018)

6.3.       Immuno Histochemistry

6.3.1.  Global Immuno Histochemistry Sales and Growth Rate (2014-2018)

6.4.       Digital Pathology

6.4.1.  Global Digital Pathology Sales and Growth Rate (2014-2018)

6.5.       In-Situ Hybridization

6.5.1.  Global In-Situ Hybridization Sales and Growth Rate (2014-2018)

6.6.       Special Staining 

6.6.1.  Global Special Staining Sales and Growth Rate (2014-2018)

7.       Tissue Diagnostics Market, By End User

7.1.       Introduction

7.2.       Global Tissue Diagnostics Sales, Revenue and Market Share by End User (2014-2018)

7.2.1.  Global Tissue Diagnostics Sales and Sales Share by End User (2014-2018)

7.2.2.  Global Tissue Diagnostics Revenue and Revenue Share by End User (2014-2018)

7.3.       Ambulatory Surgical Centers

7.3.1.  Global Ambulatory Surgical Centers Sales and Growth Rate (2014-2018)

7.4.       Diagnostic Centers

7.4.1.  Global Diagnostic Centers Sales and Growth Rate (2014-2018)

7.5.       Hospitals

7.5.1.  Global Hospitals Sales and Growth Rate (2014-2018)

7.6.       Research Laboratories

7.6.1.  Global Research Laboratories Sales and Growth Rate (2014-2018)

8.       Tissue Diagnostics Market, By Region

8.1.       Introduction

8.2.       Global Tissue Diagnostics Sales, Revenue and Market Share by Regions

8.2.1.  Global Tissue Diagnostics Sales by Regions (2014-2018)

8.2.2.  Global Tissue Diagnostics Revenue by Regions (2014-2018)

8.3.       North America Tissue Diagnostics by Countries

8.3.1.  North America Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.3.2.  North America Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.3.3.  North America Tissue Diagnostics Sales by Countries (2014-2018)

8.3.4.  North America Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.3.5.  U.S.

8.3.5.1.    United States Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.3.5.2.    United States Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.6.  Canada

8.3.6.1.    Canada Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.3.6.2.    Canada Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.7.  Mexico

8.3.7.1.    Mexico Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.3.7.2.    Mexico Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.       Europe Tissue Diagnostics by Countries

8.4.1.  Europe Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.4.2.  Europe Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.4.3.  Europe Tissue Diagnostics Sales by Countries (2014-2018)

8.4.4.  Europe Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.4.5.  Germany

8.4.5.1.    Germany Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.4.5.2.    Germany Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  UK

8.4.6.1.    UK Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.4.6.2.    UK Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  France

8.4.7.1.    France Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.4.7.2.    France Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Russia

8.4.8.1.    Russia Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.4.8.2.    Russia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.9.  Italy

8.4.9.1.    Italy Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.4.9.2.    Italy Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.10.      Rest of Europe

8.4.10.1. Rest of Europe Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.4.10.2. Rest of Europe Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.       Asia-Pacific

8.5.1.  Asia-Pacific Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.5.3.  Asia-Pacific Tissue Diagnostics Sales by Countries (2014-2018)

8.5.4.  Asia-Pacific Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.5.5.  China

8.5.5.1.    China Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.5.5.2.    China Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  Japan

8.5.6.1.    Japan Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.5.6.2.    Japan Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Korea

8.5.7.1.    Korea Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.5.7.2.    Korea Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  India

8.5.8.1.    India Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.5.8.2.    India Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.9.  Southeast Asia

8.5.9.1.    Southeast Asia Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.5.9.2.    Southeast Asia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.10.      Rest of Asia-Pacific

8.5.10.1. Rest of Asia-Pacific Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.5.10.2. Rest of Asia-Pacific Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.       South America

8.6.1.  South America Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.6.2.  South America Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.6.3.  South America Tissue Diagnostics Sales by Countries (2014-2018)

8.6.4.  South America Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.6.5.  Brazil

8.6.5.1.    Brazil Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.6.5.2.    Brazil Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Argentina

8.6.6.1.    Argentina Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.6.6.2.    Argentina Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.7.  Columbia

8.6.7.1.    Columbia Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.6.7.2.    Columbia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.8.  Rest of South America

8.6.8.1.    Rest of South America Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.6.8.2.    Rest of South America Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.       Middle East and Africa

8.7.1.  Middle East and Africa Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.7.3.  Middle East and Africa Tissue Diagnostics Sales by Countries (2014-2018)

8.7.4.  Middle East and Africa Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.7.5.  Saudi Arabia

8.7.5.1.    Saudi Arabia Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.7.5.2.    Saudi Arabia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  United Arab Emirates

8.7.6.1.    United Arab Emirates Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.7.6.2.    United Arab Emirates Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  Egypt

8.7.7.1.    Egypt Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.7.7.2.    Egypt Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Nigeria

8.7.8.1.    Nigeria Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.7.8.2.    Nigeria Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  South Africa

8.7.9.1.    South Africa Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.7.9.2.    South Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.10.      Rest of Middle East and Africa

8.7.10.1. Rest of Middle East and Africa Tissue Diagnostics Sales and Growth Rate (2014-2018)

8.7.10.2. Rest of Middle East and Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.       Becton Dickinson

9.1.1.  Business Overview

9.1.2.  Product Type Portfolio

9.1.3.  Strategic Developments

9.1.4.  Sales, Revenue and Market Share

9.2.       Agilent Technologies

9.2.1.  Business Overview

9.2.2.  Product Type Portfolio

9.2.3.  Strategic Developments

9.2.4.  Sales, Revenue and Market Share

9.3.       Genomic Health

9.3.1.  Business Overview

9.3.2.  Product Type Portfolio

9.3.3.  Strategic Developments

9.3.4.  Sales, Revenue and Market Share

9.4.       GE Healthcare

9.4.1.  Business Overview

9.4.2.  Product Type Portfolio

9.4.3.  Strategic Developments

9.4.4.  Sales, Revenue and Market Share

9.5.       3DHISTECH

9.5.1.  Business Overview

9.5.2.  Product Type Portfolio

9.5.3.  Strategic Developments

9.5.4.  Sales, Revenue and Market Share

9.6.       Thermo Fisher Scientific

9.6.1.  Business Overview

9.6.2.  Product Type Portfolio

9.6.3.  Strategic Developments

9.6.4.  Sales, Revenue and Market Share

9.7.       Roche Diagnostics

9.7.1.  Business Overview

9.7.2.  Product Type Portfolio

9.7.3.  Strategic Developments

9.7.4.  Sales, Revenue and Market Share

9.8.       Cell Signaling Technology

9.8.1.  Business Overview

9.8.2.  Product Type Portfolio

9.8.3.  Strategic Developments

9.8.4.  Sales, Revenue and Market Share

9.9.       Abbott Laboratories

9.9.1.  Business Overview

9.9.2.  Product Type Portfolio

9.9.3.  Strategic Developments

9.9.4.  Sales, Revenue and Market Share

9.10.    Danaher Corporation

9.10.1.      Business Overview

9.10.2.      Product Type Portfolio

9.10.3.      Strategic Developments

9.10.4.      Sales, Revenue and Market Share

10.   Global Tissue Diagnostics Market Competition, by Manufacturer

10.1.    Global Tissue Diagnostics Sales and Market Share by Manufacturer (2016-2017)

10.2.    Global Tissue Diagnostics Revenue and Market Share by Manufacturer (2016-2017)

10.3.    Global Tissue Diagnostics Price by Region (2016-2017)

10.4.    Top 5 Tissue Diagnostics Manufacturer Market Share

10.5.    Market Competition Trend

11.   Tissue Diagnostics Market Forecast (2018-2023)

11.1.    Global Tissue Diagnostics Sales, Revenue (Millions USD) and Growth Rate (2018-2023)

11.2.    Tissue Diagnostics Market Forecast by Regions (2018-2023)

11.2.1.      North America Tissue Diagnostics Market Forecast (2018-2023)

11.2.1.1. United States Tissue Diagnostics Market Forecast (2018-2023)

11.2.1.2. Canada Tissue Diagnostics Market Forecast (2018-2023)

11.2.1.3. Mexico Tissue Diagnostics Market Forecast (2018-2023)

11.2.2.      Europe Tissue Diagnostics Market Forecast (2018-2023)

11.2.2.1. Germany Tissue Diagnostics Market Forecast (2018-2023)

11.2.2.2. United Kingdom Tissue Diagnosticss Market Forecast (2018-2023)

11.2.2.3. France Tissue Diagnostics Market Forecast (2018-2023)

11.2.2.4. Russia Tissue Diagnostics Market Forecast (2018-2023)

11.2.2.5. Italy Tissue Diagnostics Market Forecast (2018-2023)

11.2.2.6. Rest of the Europe Tissue Diagnostics Market Forecast (2018-2023)

11.2.3.      Asia-Pacific Tissue Diagnostics Market Forecast (2018-2023)

11.2.3.1. China Tissue Diagnostics Market Forecast (2018-2023)

11.2.3.2. Japan Tissue Diagnostics Market Forecast (2018-2023)

11.2.3.3. Korea Tissue Diagnostics Market Forecast (2018-2023)

11.2.3.4. India Tissue Diagnostics Market Forecast (2018-2023)

11.2.3.5. Southeast Asia Tissue Diagnostics Market Forecast (2018-2023)

11.2.3.6. Rest of Asia-Pacific Tissue Diagnostics Market Forecast (2018-2023)

11.2.4.      South America Tissue Diagnostics Market Forecast (2018-2023)

11.2.4.1. Brazil Tissue Diagnostics Market Forecast (2018-2023)

11.2.4.2. Argentina Tissue Diagnostics Market Forecast (2018-2023)

11.2.4.3. Columbia Tissue Diagnostics Market Forecast (2018-2023)

11.2.4.4. Rest of South America Tissue Diagnostics Market Forecast (2018-2023)

11.2.5.      Middle East and Africa Tissue Diagnostics Market Forecast (2018-2023)

11.2.5.1. Saudi Arabia Tissue Diagnostics Market Forecast (2018-2023)

11.2.5.2. UAE Tissue Diagnostics Market Forecast (2018-2023)

11.2.5.3. Egypt Tissue Diagnostics Market Forecast (2018-2023)

11.2.5.4. Nigeria Tissue Diagnostics Market Forecast (2018-2023)

11.2.5.5. South Africa Tissue Diagnostics Market Forecast (2018-2023)

11.2.5.6. Rest of MEA Tissue Diagnostics Market Forecast (2018-2023)

11.3.    Tissue Diagnostics Market Forecast by Product Type (2018-2023)

11.3.1.      Global Tissue Diagnostics Sales Forecast by Product Type (2018-2023)

11.3.2.      Global Tissue Diagnostics Sales Market Share Forecast by Product Type (2018-2023)

11.4.    Tissue Diagnostics Market Forecast by Technology (2018-2023)

11.4.1.      Global Tissue Diagnostics Sales Forecast by Technology (2018-2023)

11.4.2.      Global Tissue Diagnostics Sales Market Share Forecast by Technology (2018-2023)

11.5.    Tissue Diagnostics Market Forecast by End User (2018-2023)

11.5.1.      Global Tissue Diagnostics Sales Forecast by End User (2018-2023)

11.5.2.      Global Tissue Diagnostics Sales Market Share Forecast by End User (2018-2023)


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Tissue Diagnostics Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*